亨迪药业：9月18日将召开2025年第二次临时股东大会

Group 1 - The company, Hendi Pharmaceutical, announced that it will hold its second extraordinary general meeting of shareholders on September 18, 2025 [2] - The agenda for the meeting includes proposals to change the company's registered capital, amend the articles of association, and handle business registration changes [2] - Additionally, the meeting will review proposals to revise certain governance systems of the company [2]